CompletedPhase 1/2

Autologous Platelet Lysate in Corneal Epithelial Defects

Jordan10 participantsStarted 2017-02-16

Plain-language summary

Patients diagnosed with persistent corneal epithelial ulcers will be treated with autologous platelet lysate.

Age range21 Years – 78 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✓. Cognitive ability to understand and sign the consent form.
✓. Corneal ulcers that did not re-epithelialise after 1 week of conventional treatment (therapeutic contact lenses, topical artificial tears, eye packs and antibiotic eye-drops).
✓. Clinical indications: corneal ulcer due to caustic substances, corneal epitheliopathy, corneal lesions following cataract surgery, recurrent ulcerative keratitis, corneal lesions due to a foreign body.
✓. Good compliance with the study regimen and availability for the duration of the entire study period.

Incidence of Treatment-Emergent Adverse Events [Safety and Tolerability]) as a result of the eye drops

Timeframe: 2 months

NCT IDNCT02979912

SponsorHanan Jafar

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-01-15